UC8-16866-79736
4 vaccinations
3 coded responses
44 check-ins
2 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 283 / NC
- Registered
- 2020-12-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
R4V-21010-33684
Child or adolescent in my care · Female · 2021-11-09
Timeline
-
2020-12-15
Registered in v-safe
-
2020-12-15
Dose 1 — Pfizer-BioNTech
- 2020-12-15
- 2020-12-16
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-29
-
2021-01-05
Dose 2 — Pfizer-BioNTech
-
2021-01-05
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-05
Report sent to call center — day 0, dose 2Be unable to do your normal daily activities2 call case(s)
-
2021-01-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-06
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities2 call case(s)
-
2021-01-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-04-06
- 2021-07-06
-
2021-09-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-09-29
Survey response — day 0, dose 3MedDRA: Dizziness — Feeling: Good · Site: PainFree text: DizzyMedDRA releases: 2024-11 · check-in free text available
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-10
- 2021-12-29
- 2022-03-30
-
2022-09-15
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-29
Survey response — 12 months, dose 3MedDRA: COVID-19, Fatigue, Headache, Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: COVID. Severe headache, fever and fatigue.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-16
- 2022-10-20
- 2022-10-27
- 2022-12-15
-
2023-03-16
Survey response — 6 months, dose 4MedDRA: Fibrosis, Oedema peripheral, Peripheral vein stenosis, Surgery, Vascular stent insertion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-03-16
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-15 | Pfizer-BioNTech | |
| 2 | 2021-01-05 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-15 | Pfizer-BioNTech | Flu |
Call center
5 call center cases
1 unsuccessful · 4 priority 2/3 (triaged and no follow up)
Free text
Release 9 — day 0, dose 3
Systemic reaction (other): Dizzy
Release 12 — 12 months, dose 3
Symptoms: COVID. Severe headache, fever and fatigue.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Fibrosis | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oedema peripheral | · | · | ✓ |
| SD | Peripheral vein stenosis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Vascular stent insertion | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release